Iridex Corp Reports Results For The Quarter Ended June 30: Earnings Summary
IRIDEX Corp reports results for the quarter ended June 30 - Earnings Summary
IRIDEX Corp IRIX.OQ reported a quarterly adjusted loss of 7 cents per share for the quarter ended June 30. The lone analyst forecast for the quarter was for a loss of one cent per share.
Revenue was $12.57 million; analysts expected $13.59 million.
IRIDEX Corp's reported EPS for the quarter was a loss of 7 cents.
The company reported a quarterly loss of $1.27 million.
IRIDEX Corp shares had fallen by 23.1% this quarter and lost 22.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 50% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for IRIDEX Corp is $2.75, about 68% above its last closing price of $0.88
This summary was machine generated from LSEG data August 18 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.01 | -0.07 | Missed |
Mar. 31 2026 | -0.07 | -0.03 | Beat |
Dec. 31 2025 | -0.02 | -0.01 | Beat |